Greenwich (GLSI) news
Recent news
Greenwich Lifesciences - extends lock-up of directors, officers, pre-IPO investors' shares to January 31, 2027
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) has announced that its Board of Directors has extended the lock-up period for shares owned by directors, officers, and pre-IPO investors to January 31, 2027. This extension adds to the previously announced lock-up period, which was expire on September 30,…
AInvest Wire · Aug 10, 2026H.C. Wainwright raises target price to $69 from $50 for Greenwich Lifesciences, Inc.
H.C. Wainwright has revised its target price for Greenwich Lifesciences, Inc. (NASDAQ: GLNC), raising it from $50 to $69, reflecting a 38% increase in the firm’s price objective. The adjustment follows a recent analysis of the company’s strategic direction and operational performance. The analyst…
AInvest Wire · Jul 21, 2026Greenwich Lifesciences - Q2 2026 burn rate expected at $2 mln; cash balance $8.90 mln as of June 30, 2026
AInvest Wire · Jul 20, 2026Greenwich Lifesciences - Flamingo-01 Phase 3 objectives met following FDA and EMA review
AInvest Wire · Jul 20, 2026Greenwich Lifesciences - Flamingo-01 steering committee endorses study size increase and accelerated enrollment
AInvest Wire · Jul 20, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.